Recommendations made out-of-session by the PBAC March 2023 and July 2023 meetings – Changes to MS-2 Step® PBS Listing

Recommendations made out-of-session by the PBAC March 2023 and July 2023 meetings – Changes to MS-2 Step® PBS Listing

11 Jul 2023

In an out-of-session consideration, the PBAC has recommended changes to the restriction criteria and eligible prescriber types for the PBS listings of mifepristone and misoprostol (MS-2 Step®).       

Details of the PBAC’s recommendation can be found on the ‘Recommendations made out-of-session by the PBAC between meetings’

 webpage under ‘Recommendations made out-of-session by the Pharmaceutical Benefits Advisory Committee (PBAC) between its March 2023 and July 2023 meetings’

Categories

Popular Posts

Tags